Evan Leibowitz
Rheumatology · Midland Park, NJNPI 1235194986
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $146,498 of the $187,668 with a category attached, or 78.1%. 14 manufacturers reported payments, led by Janssen Scientific Affairs, LLC at 52.9% of the total. Reporting peaked in 2019 at $105,561 and has fallen 99.9% since, to $61 in 2025. Among rheumatology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 400 payments — averaging $469.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Scientific Affairs, LLC$99K
- Lilly USA, LLC$20K
- Novartis$20K
- E.r. Squibb & Sons, L.L.C.$19K
- AstraZeneca$16K
- Johnson & Johnson$8K
- plus $5K from 8 others
Across 16 payments — averaging $6978.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$77K
- Swedish Orphan Biovitrum AB$19K
- AbbVie$15K
- E.r. Squibb & Sons, L.L.C.$523
What the payments were for
- Consulting fees$18,30010%
- Speaking & faculty fees$146,49878%
- Travel & lodging$17,3669%
- Food & beverage$5,3373%
- Education$1660%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Scientific Affairs, LLC | 70 | $99,315 |
| Lilly USA, LLC | 51 | $20,192 |
| Novartis | 67 | $20,057 |
| E.r. Squibb & Sons, L.L.C. | 76 | $18,834 |
| AstraZeneca | 19 | $16,364 |
| Johnson & Johnson(2 entities) | 70 | $8,222 |
| Amgen(2 entities) | 17 | $4,210 |
| AbbVie | 12 | $178 |
| Genentech USA, Inc. | 9 | $150 |
| Heartflow, Inc. | 5 | $93 |
| Pfizer | 1 | $15 |
| Sanofi | 1 | $13 |
| Hikma Pharmaceuticals USA | 1 | $13 |
| IBSA Pharma Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$187,668 in reported general payments places this provider in the 95th percentile of 234 rheumatology providers in New Jersey.
Other rheumatology in Midland Park
- Arik ZaiderMidland Park$28K
- Michael KneeMidland Park$20K
- Lori CoxNew Brunswick$1.4M
- Richard HaddadRed Bank$1.1M
- Kiren SahniWest Long Branch$569K
- Jeffrey GreenbergSummit$399K
- Steven GolombekDover$318K
- Nicholas ScarpaJersey City$281K
- Adrienne HollanderVoorhees$214K
- Edward AllegraRed Bank$212K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.